Individualized Ofatumumab versus Fixed Low‐Dose Rituximab in MuSK‐Antibody‐Positive Myasthenia Gravis: A Multicenter Retrospective Cohort Study

Clinical Neurology and Neurosurgery · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles